Rainbow Childrens Medicare Ltd

Q1 FY26Healthcare Services

Rainbow Childrens Medicare Ltd Q1 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹1,433

Market cap₹16.2K Cr

P/E56.7

Updated23 Aug 2026

Read4 min read

The short version

Revenue growth guidance remains in the late teens to around 20%, supported by bed additions and recent acquisitions. Rainbow Children’s Medicare expects late teens to around 20% revenue growth in the near term, supported by bed additions and acquisitions.

From Rainbow Childrens Medicare Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Revenue growth guidance remains in the late teens to around 20%, supported by bed additions and recent acquisitions.
Addition of roughly 350 beds expected this year (250 coming into operation in 2-3 months plus 100 from recent Warangal acquisition).
New hospitals like Sarjapur have reached breakeven; Anna Nagar nearing breakeven within six months.
Expansion into new geographies such as NCR, Pune, and Northeast underway, targeting cities with strong IT and knowledge-based job ecosystems.
Continued focus on strengthening sales and marketing teams to achieve sustainable, scalable growth.
The project pipeline is intact, with timelines for new hospitals (e.g., Gurugram operations targeted around September-October 2027).
Organic and inorganic growth opportunities (acquisitions, greenfield, and brownfield projects) are key to future expansion.
Management acknowledges current challenges like degrowth in birthing volumes but optimistic for recovery and growth by year-end.

Profitability & Margins

Rainbow Children’s Medicare expects late teens to around 20% revenue growth in the near term, supported by bed additions and acquisitions.
EBITDA margin improved by ~1% in Q1 FY26; no specific margin guidance provided but cost discipline is noted.
Profit after tax grew 35% YoY in Q1 FY26 signaling strong profitability momentum.
Addition of 350 beds operational this year (250 beds coming soon, plus 100 from recent Warangal acquisition) is expected to drive growth.
New hospitals like Sarjapur have reached breakeven; Anna Nagar expected to break even in ~6 months, aiding margin expansion.
ARPP (Average Revenue Per Patient) is on a 6-7% upward trend; 3-3.5% full-year ARPP growth is expected.
Continued investments funded from cash reserves and internal accruals, with no planned debt financing, indicate capacity for sustained expansion.
Management will reassess growth trends towards end of the year; currently cautious due to seasonal/competitive factors.

See what Rainbow Childrens Medicare Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The company invested approximately INR 41.5 crores in capital expenditure during the quarter.
They are advancing an asset-light build-to-suit greenfield hospital in Pune with 150 beds, expected to cost around INR 80 lakhs per bed, with signing anticipated within weeks.
The Pune hospital is planned to commence operations approximately 2.5 years after signing.
The Rajahmundry 100-bed regional hub hospital project is complete and awaiting government permissions to begin operations.
Two spoke hospitals in Bengaluru are targeted for commissioning this year.
Internal accruals and existing cash of INR 735 crores are expected to fully fund ongoing and planned capital expenditure without debt financing.
The company is exploring inorganic acquisitions and greenfield/brownfield projects to support future growth.

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹981 Cr

Rev 1Mar 1

2CHANDAN₹518 Cr

Rev 1Mar 3

3₹66.5K Cr

Rev 2Mar 1

4₹654 Cr

Rev 2Mar 2

5₹1.3L Cr

Rev 2Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

Rainbow Children's Medicare Limited currently has a robust net cash position of INR 735 crores as of June 30, 2025.
The company plans to fund ongoing capital expenditure entirely through internal accruals and existing cash, without any debt financing.
Given their current cash and anticipated internal accruals, they are confident in completing all planned capital expenditures without raising debt.
There is no mention of any immediate or future fundraising through equity or debt in the provided transcript.
The focus remains on organic growth, greenfield and brownfield expansions, and selective inorganic acquisitions funded internally.

See what Rainbow Childrens Medicare Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided does not explicitly mention current or expected order book or pending orders in numerical terms. However, some relevant details related to projects and capacity expansion are as follows: - The company has an ongoing project pipeline with disciplined execution. - A regional hub hospital in Rajahmundry (100 beds) has been completed and is awaiting final government permissions to commence operations. - The company is planning to add around 800 beds over the next 3 years, with approximately 450 beds in Gurugram. - Around 50% of the total planned bed additions will be on an asset-light model. - Discussions are advanced for an asset-light build-to-suit greenfield hospital in Pune with 150 bed capacity. - Entry into new markets such as Warangal and Pune is underway, with Warangal acquisition completed (76% stake in Prashanthi Hospital). - Operations at new Gurugram hospitals are targeted to start around September-October 2027. No specific order book values or pending orders amounts are disclosed in the transcript.

Rainbow Childrens Medicare Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹460 Cr, net profit ₹78 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Rainbow Childrens Medicare Ltd's management said in earlier quarters

Others in Healthcare Services this season

Aster DM Quality Care Ltd (Q1 FY26)
Recent quarters saw subdued volume growth due to leadership changes and seasonal effects, but an 8% volume growth was achieved in Q1 FY26, improving from 2% in…
Dr Agarwals Health Care Ltd (Q1 FY26)
70 crores via preferential allotment to AEHL for CAPEX plans, particularly the flagship facility at Cathedral Road, indicating capacity and service…
Syngene International Ltd (Q1 FY26)
Operating EBITDA grew 21% YoY in Q1 FY '26 with margins rising to ~24% from 22% last year. Key concall takeaways from Syngene International Ltd's Q1 FY26…
Yatharth Hospital & Trauma Care Services Ltd (Q1 FY26)
International patient business is growing but will remain around 10% of revenue, positively impacting ARPOB without hurting margins. Key concall takeaways from…

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare Institute Ltd vs Manipal Health Enterprises Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Rainbow Childrens Medicare Ltd Q1 FY26 results?

What is Rainbow Childrens Medicare Ltd share price analysis?

Rainbow Childrens Medicare Ltd currently shows a neutral. The stock trades at a P/E of 56.7 with a market cap of ₹16,236 Cr. Investors should review the full earnings analysis for detailed insights.

Is Rainbow Childrens Medicare Ltd planning capital expenditure?

The company invested approximately INR 41.5 crores in capital expenditure during the quarter.

Keep Rainbow Childrens Medicare Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.